Probi® was born out of a visionary research project at Lund University, Sweden, whose aim was to discover whether administering specific probiotics to critically ill patients could enhance therapeutic outcomes and improve their chances of recovery.
Based on the success of this project, which began in the mid-1980s, a patent application was filed for Lactoplantibacillus plantarum 299v (LP299V®) today the company’s most studied bacterial strain. This research was the genesis of Probi’s founding in 1991.
Professor Bengt Jeppsson was a true probiotic pioneer and is also one of the founders of Probi. Listen to his story!